Understanding COVID-19 Vaccine Hesitancy in the United States: A Systematic Review.

Publication date: Jul 06, 2024

The COVID-19 pandemic has presented the importance of vaccination as a pivotal strategy for controlling its spread. However, vaccine hesitancy poses a significant barrier to achieving widespread immunization in the United States. This systematic review utilizes the 5C model to examine the factors contributing to hesitancy, which include confidence in vaccines, complacency about disease risk, calculations of individual benefit, convenience of vaccination, and collective responsibility for the protection of others. We conducted a comprehensive search across several relevant databases and the gray literature, identifying 544 studies that used quantitative and qualitative methods to explore COVID-19 vaccine hesitancy in the general U. S. This review identifies a complex interplay of factors affecting hesitancy, such as concerns over vaccine safety and efficacy, misinformation and conspiracy theories, demographic variables, and socioeconomic conditions. Key strategies for increasing vaccine uptake include transparent and effective communication along with proactive community engagement. To effectively mitigate vaccine hesitancy, it is crucial to understand its multifaceted causes. Tailored interventions that consider socioeconomic and cultural contexts and prioritize clear communication, community involvement, and specific strategies to address unique concerns can enhance vaccine acceptance.

Open Access PDF

Concepts Keywords
Conspiracy COVID-19 pandemic
Covid misinformation
Proactive mistrust
Socioeconomic United States
Vaccine vaccination
vaccine acceptance
vaccine hesitancy
vaccine perceptions
vaccine safety
vaccine uptake

Semantics

Type Source Name
disease VO COVID-19 vaccine
disease MESH COVID-19 pandemic
disease VO vaccination
disease VO vaccine
disease VO immunization
disease VO effective
disease MESH causes
disease VO USA
disease VO population
disease MESH Infectious Diseases
disease VO organization
disease MESH death
disease IDO facility
drug DRUGBANK Coenzyme M
disease VO dose
disease VO vaccinated
drug DRUGBANK Stavudine
drug DRUGBANK Hydroxyethyl Starch
disease VO Apa
disease IDO process
drug DRUGBANK Methionine
disease VO publication
disease VO frequency
disease VO age
disease VO unvaccinated
disease IDO country
disease IDO history
disease VO manufacturer
disease VO ineffective
disease VO Optaflu
disease VO influenza vaccines
disease IDO production
disease IDO quality
disease VO effectiveness
disease IDO host
disease VO document
drug DRUGBANK Polyethylene glycol
disease MESH Allergy
disease MESH syphilis
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Gold
drug DRUGBANK Efavirenz
disease MESH influenza
disease VO vaccine dose

Original Article

(Visited 2 times, 1 visits today)